Pharmaceutical composition
    8.
    发明授权
    Pharmaceutical composition 失效
    药物组成

    公开(公告)号:US4983605A

    公开(公告)日:1991-01-08

    申请号:US110284

    申请日:1987-10-20

    摘要: A pharmaceutical composition comprising a benzoyl urea compound (A) selected from the group consisting of a benzoyl urea compound (I) having the formula: ##STR1## wherein X is a halogen atom, a nitro group or a trifluoromethyl group, provided that when Y is a nitro group, X is a halogen atom or a nitro group, Y is a hydrogen atom, a halogen atom, a nitro group or a trifluoromethyl group, Z.sub.1 is a halogen atom or a trifluoromethyl group, Z.sub.2 is a hydrogen atom or a halogen atom, and A is a .dbd.CH-- group or a nitrogen atom, and a benzoyl urea compound (II) having the formula: ##STR2## wherein each of X.sub.1 and X.sub.2 is a hydrogen atom, a halogen atom or a nitro group, provided that when Y is a nitro group, X.sub.1 is a hydrogen atom, Y is a hydrogen atom, a halogen atom, a nitro group or a trifluoromethyl group, and Z is a hydrogen atom, a halogen atom or a trifluoromethyl group, as an active ingredient; a nonionic surfactant as a dispersant; and at least one member selected from the group consisting of a saccharide, a saccharide alcohol, silicic anhydride and a nonionic surfactant, as a disintegrator.

    摘要翻译: 提供一种药物组合物,其包含选自具有下式的苯甲酰脲化合物(I)的苯甲酰脲化合物(A):其中X为卤素原子,硝基或三氟甲基,其提供 当Y为硝基时,X为卤原子或硝基,Y为氢原子,卤原子,硝基或三氟甲基,Z1为卤原子或三氟甲基,Z2为氢 原子或卤素原子,A为= CH-基或氮原子,和具有下式的苯甲酰脲化合物(II):其中X1和X2各自为氢原子,卤素 原子或硝基,条件是当Y为硝基时,X 1为氢原子,Y为氢原子,卤素原子,硝基或三氟甲基,Z为氢原子,卤素原子或 三氟甲基作为活性成分; 作为分散剂的非离子表面活性剂; 和选自糖,糖醇,硅酸酐和非离子表面活性剂的至少一种作为崩解剂。